The Almond Yogurt Study (AYS) (AYS)
The Impact of Almond Food Structure in a Standardized Yogurt Breakfast Meal on Gastric Emptying, Oral Processing Behaviours, Appetite-Regulating Hormones, Postprandial Metabolism, and Subjective Satiety: A Randomized Crossover Trial
The goal of this clinical trial is to explore how almond food structure influences gastric emptying rates when consumed by healthy adult women as part of a standardized breakfast meal. The main questions it aims to answer are:
- Does the structure of almonds (whole, chopped, buttered) influence gastric emptying ?
- What is the correlation between chewing behaviour, gastric emptying, and changes in postprandial triacylglycerols and satiety (hormones and ratings) within the context of an increasingly disrupted nut matrix.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
This study is investigating how the structure of almonds (whole, chopped, buttered) as part of a yogurt-based breakfast meal influences gastric emptying and postprandial metabolism. Over three randomized visits, fasted healthy adult female participants will arrive at the research centre where an iv-catheter will be inserted for serial blood sampling over 6 hours for analysis of plasma triacylglycerols, GLP-1, CCK, glucose, and insulin. Participants will consume each meal while being video recorded to quantify chewing frequency and eating time. Paper questionnaires will periodically assess participants' eating experiences and hunger sensations throughout the visit (e.g., exertion, liking, hunger, fullness). Gastric ultrasonography will be used to visualize and quantify the cross-sectional area of the gastric antrum so that changes in gastric volume can be tracked over time. Overall, this study aims to determine how almond form, as an example of food structure, influences chewing, gastric emptying, satiety and postprandial metabolism.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Amanda J Wright, PhD
- Número de telefone: 54697 519-824-4120
- E-mail: ajwright@uoguelph.ca
Locais de estudo
-
-
Ontario
-
Guelph, Ontario, Canadá, N1G 2G4
- Department of Human Health Sciences
-
Contato:
- Amanda J Wright, PhD
- Número de telefone: 54697 5190824-4120
- E-mail: ajwright@uoguelph.ca
-
Contato:
- Alison M Duncan, PhD
-
Investigador principal:
- Amanda J Wright, PhD
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Healthy female adults aged 18-45 years.
- Body Mass Index (BMI) between 18.5-27.9 kg/m2, or waist circumference of less than 88 cm
- Visible gastric antrum on ultrasound
- No known food allergies or sensitivities
- Non restrained eaters (TFEQ, see below)
- No history of gastrointestinal diseases that may interfere with eating behavior or digestion
- Not on medications that affect appetite (including GLP-1 agonists), digestion, blood sugar regulation, saliva production, or chewing
- Stable medication use
- Non-smokers
- Not gained or lost significant weight during the past 3 months
- Regular monthly menstrual cycles
- Not pregnant, lactating or post-menopausal
Exclusion Criteria:
- Diabetes or other metabolic disorders affecting glycemia and overall cardiometabolic health
- Blood pressure > 140/90 mm Hg
- Any food allergies, intolerances, or sensitivities
- Pregnant or breastfeeding
- Participation in another clinical trial
- Excessive alcohol consumption (more than 14 drinks per week)
- Smokers or those with a smoking history of more than 10 years
- Regular use of recreational drugs (e.g., marijuana, ecstasy, LSD, magic mushrooms, etc.)
- Restrained eater (>16) as defined by the questionnaire at screening (Three-Factor Eating Questionnaire, Stunkard et al., 1985)
- Unusual sleep patterns
- Irregular breakfast consumption
- Recent weight changes, or intended weight loss or gain; lost/gained 10% of body weight within the last 6 months
- Food allergies/sensitivities or any life-threatening allergies
- Using medications known to affect appetite, digestion, blood sugar regulation, or chewing/swallowing (excluding oral contraceptives).
- Experiences dry mouth in general or due to medication side effects
- Inability to adhere to study protocols
- Not comfortable providing IV-line blood samples
- Not comfortable providing ultrasound scans
- Not comfortable being video recorded while eating
- Avoids consuming almonds/yogurt in general
- Avoids eating hard foods to prevent dental fractures
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Dobro
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Whole - Chopped - Buttered
Participants consume 115 g vanilla yogurt with 60 g whole almonds at the first intervention visit, chopped almonds at the second intervention visit, and almonds processed into almond butter at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Experimental: Whole - Buttered - Chopped
Participants consume 115 g vanilla yogurt with 60 g whole almonds at the first intervention visit, buttered almonds at the second intervention visit, and chopped almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Experimental: Buttered - Whole - Chopped
Participants consume 115 g vanilla yogurt with 60 g buttered almonds at the first intervention visit, whole almonds at the second intervention visit, and chopped almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Experimental: Buttered - Chopped - Whole
Participants consume 115 g vanilla yogurt with 60 g buttered almonds at the first intervention visit, chopped almonds at the second intervention visit, and whole almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Experimental: Chopped - Buttered - Whole
Participants consume 115 g vanilla yogurt with 60 g chopped almonds at the first intervention visit, buttered almonds at the second intervention visit, and whole almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
|
Experimental: Chopped - Whole - Buttered
Participants consume 115 g vanilla yogurt with 60 g chopped almonds at the first intervention visit, whole almonds at the second intervention visit, and buttered almonds at the third intervention visit. |
Breakfast meal consisting of vanilla yogurt (115g) with almonds (60g) in different forms. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Gastric emptying half-time
Prazo: At each study visit, based on assessments at 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated from ultrasound imaging of the gastric antrum cross-sectional area at baseline (fasted) and after consumption of the breakfast meal, in minutes |
At each study visit, based on assessments at 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Eating time
Prazo: From 0 minutes until the end of eating the breakfast meal
|
The time to consume the breakfast meal based on video recordings, in minutes |
From 0 minutes until the end of eating the breakfast meal
|
|
Changes from baseline in postprandial satiety visual analogue scale ratings
Prazo: 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Paper questionnaire scale ratings (in mm) of Hunger, Fullness, Prospective Consumption, and Desire to Eat where each is 100 mm ranging from 0 (minimum) to 100 (maximum). For example, 0 = Not at all Hungry and 100 = As Hungry as Possible. |
0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma triacylglycerol concentration
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in mmol/L |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Triacylglycerol response - incremental area under the curve (AUC)
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma GLP-1 concentration
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in pg/mL |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
GLP-1 response - incremental area under the curve (AUC)
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma CCK concentration
Prazo: 0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in pmol/L |
0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
CCK response - incremental area under the curve (AUC)
Prazo: 0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in gastric volume
Prazo: 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on ultrasound imaging of the gastric antrum cross-sectional area at baseline (fasted) and after eating the breakfast meal, in mL |
0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Gastric volume - incremental area under the curve (AUC)
Prazo: 0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on ultrasound imaging of the gastric antrum cross-sectional area at baseline (fasted) and after eating the breakfast meal |
0, 0.5, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Outras medidas de resultado
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Borg rating of perceived exertion
Prazo: Immediately after the breakfast meal is consumed
|
Participant paper scale rating of effort required to chew the breakfast meal where 0 = No effort at all and 10 = Very very severe chewing effort |
Immediately after the breakfast meal is consumed
|
|
Changes from baseline in plasma blood glucose concentration
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in mmol/mL |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Glucose response - incremental area under the curve (AUC)
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Changes from baseline in plasma blood insulin concentration
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Based on analysis of serial blood draws, in pmol/mL |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Insulin response - Area under the curve (AUC)
Prazo: 0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
Calculated based on baseline and postprandial plasma concentrations |
0, 1, 2, 3, 4, 5, & 6 hours from the start of eating the breakfast meal
|
|
Product liking and perceived attributes
Prazo: Immediately after eating the breakfast meal
|
Participant paper scale questionnaire ratings |
Immediately after eating the breakfast meal
|
|
Eating rate
Prazo: From 0 minutes until the end of eating the breakfast meal
|
Calculated from video recordings of eating session, combining meal portion consumed (in grams) and eating time (minutes), grams/minute |
From 0 minutes until the end of eating the breakfast meal
|
|
Number of chews
Prazo: From 0 minutes until the end of eating the breakfast meal
|
Determined by count from video recordings of each eating session |
From 0 minutes until the end of eating the breakfast meal
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- ID3014
- 400819 (Número de outro subsídio/financiamento: Natural Sciences & Engineering Research Council of Canada)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Although we are not required to make this data available, we are currently working to understand how to do this in a safe way, as per our institutional guidelines. As we learn more, we may pursue this. We are obtaining consent from study participants for this option.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .